Global Astragaloside IV Market Insights, Forecast to 2026
Astragaloside IV market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Astragaloside IV market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Astragaloside IV market is segmented into
Segment by Application, the Astragaloside IV market is segmented into
The Astragaloside IV market is analysed and market size information is provided by regions (countries).
The key regions covered in the Astragaloside IV market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Astragaloside IV Market Share Analysis
Astragaloside IV market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Astragaloside IV business, the date to enter into the Astragaloside IV market, Astragaloside IV product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Astragaloside IV market is segmented into
- 0.1
- 0.98
- Others
Segment by Application, the Astragaloside IV market is segmented into
- Food Industry
- Pharmaceuticals Industry
- Others
The Astragaloside IV market is analysed and market size information is provided by regions (countries).
The key regions covered in the Astragaloside IV market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Astragaloside IV Market Share Analysis
Astragaloside IV market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Astragaloside IV business, the date to enter into the Astragaloside IV market, Astragaloside IV product introduction, recent developments, etc.
The major vendors covered:
- NandR Bio Industries
- Zenergy Korea Corporation
- Bio-norm
- Wuhan Vanz Pharm
- Shaanxi Pioneer Biotech
- Xi'an Lyphar Biotech
- Xian Pincredit Bio-Tech
- Shaanxi Fuheng (FH) Biotechnology
1 STUDY COVERAGE
1.1 Astragaloside IV Product Introduction
1.2 Market Segments
1.3 Key Astragaloside IV Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Astragaloside IV Market Size Growth Rate by Type
1.4.2 0.1
1.4.3 0.98
1.4.4 Others
1.5 Market by Application
1.5.1 Global Astragaloside IV Market Size Growth Rate by Application
1.5.2 Food Industry
1.5.3 Pharmaceuticals Industry
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Astragaloside IV Industry Impact
1.6.1 How the Covid-19 is Affecting the Astragaloside IV Industry
1.6.1.1 Astragaloside IV Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Astragaloside IV Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Astragaloside IV Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Astragaloside IV Market Size Estimates and Forecasts
2.1.1 Global Astragaloside IV Revenue 2015-2026
2.1.2 Global Astragaloside IV Sales 2015-2026
2.2 Astragaloside IV Market Size by Region: 2020 Versus 2026
2.2.1 Global Astragaloside IV Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Astragaloside IV Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL ASTRAGALOSIDE IV COMPETITOR LANDSCAPE BY PLAYERS
3.1 Astragaloside IV Sales by Manufacturers
3.1.1 Astragaloside IV Sales by Manufacturers (2015-2020)
3.1.2 Astragaloside IV Sales Market Share by Manufacturers (2015-2020)
3.2 Astragaloside IV Revenue by Manufacturers
3.2.1 Astragaloside IV Revenue by Manufacturers (2015-2020)
3.2.2 Astragaloside IV Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Astragaloside IV Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Astragaloside IV Revenue in 2019
3.2.5 Global Astragaloside IV Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Astragaloside IV Price by Manufacturers
3.4 Astragaloside IV Manufacturing Base Distribution, Product Types
3.4.1 Astragaloside IV Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Astragaloside IV Product Type
3.4.3 Date of International Manufacturers Enter into Astragaloside IV Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Astragaloside IV Market Size by Type (2015-2020)
4.1.1 Global Astragaloside IV Sales by Type (2015-2020)
4.1.2 Global Astragaloside IV Revenue by Type (2015-2020)
4.1.3 Astragaloside IV Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Astragaloside IV Market Size Forecast by Type (2021-2026)
4.2.1 Global Astragaloside IV Sales Forecast by Type (2021-2026)
4.2.2 Global Astragaloside IV Revenue Forecast by Type (2021-2026)
4.2.3 Astragaloside IV Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Astragaloside IV Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Astragaloside IV Market Size by Application (2015-2020)
5.1.1 Global Astragaloside IV Sales by Application (2015-2020)
5.1.2 Global Astragaloside IV Revenue by Application (2015-2020)
5.1.3 Astragaloside IV Price by Application (2015-2020)
5.2 Astragaloside IV Market Size Forecast by Application (2021-2026)
5.2.1 Global Astragaloside IV Sales Forecast by Application (2021-2026)
5.2.2 Global Astragaloside IV Revenue Forecast by Application (2021-2026)
5.2.3 Global Astragaloside IV Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Astragaloside IV by Country
6.1.1 North America Astragaloside IV Sales by Country
6.1.2 North America Astragaloside IV Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Astragaloside IV Market Facts & Figures by Type
6.3 North America Astragaloside IV Market Facts & Figures by Application
7 EUROPE
7.1 Europe Astragaloside IV by Country
7.1.1 Europe Astragaloside IV Sales by Country
7.1.2 Europe Astragaloside IV Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Astragaloside IV Market Facts & Figures by Type
7.3 Europe Astragaloside IV Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Astragaloside IV by Region
8.1.1 Asia Pacific Astragaloside IV Sales by Region
8.1.2 Asia Pacific Astragaloside IV Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Astragaloside IV Market Facts & Figures by Type
8.3 Asia Pacific Astragaloside IV Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Astragaloside IV by Country
9.1.1 Latin America Astragaloside IV Sales by Country
9.1.2 Latin America Astragaloside IV Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Astragaloside IV Market Facts & Figures by Type
9.3 Central & South America Astragaloside IV Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Astragaloside IV by Country
10.1.1 Middle East and Africa Astragaloside IV Sales by Country
10.1.2 Middle East and Africa Astragaloside IV Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Astragaloside IV Market Facts & Figures by Type
10.3 Middle East and Africa Astragaloside IV Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 NandR Bio Industries
11.1.1 NandR Bio Industries Corporation Information
11.1.2 NandR Bio Industries Description, Business Overview and Total Revenue
11.1.3 NandR Bio Industries Sales, Revenue and Gross Margin (2015-2020)
11.1.4 NandR Bio Industries Astragaloside IV Products Offered
11.1.5 NandR Bio Industries Recent Development
11.2 Zenergy Korea Corporation
11.2.1 Zenergy Korea Corporation Corporation Information
11.2.2 Zenergy Korea Corporation Description, Business Overview and Total Revenue
11.2.3 Zenergy Korea Corporation Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Zenergy Korea Corporation Astragaloside IV Products Offered
11.2.5 Zenergy Korea Corporation Recent Development
11.3 Bio-norm
11.3.1 Bio-norm Corporation Information
11.3.2 Bio-norm Description, Business Overview and Total Revenue
11.3.3 Bio-norm Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Bio-norm Astragaloside IV Products Offered
11.3.5 Bio-norm Recent Development
11.4 Wuhan Vanz Pharm
11.4.1 Wuhan Vanz Pharm Corporation Information
11.4.2 Wuhan Vanz Pharm Description, Business Overview and Total Revenue
11.4.3 Wuhan Vanz Pharm Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Wuhan Vanz Pharm Astragaloside IV Products Offered
11.4.5 Wuhan Vanz Pharm Recent Development
11.5 Shaanxi Pioneer Biotech
11.5.1 Shaanxi Pioneer Biotech Corporation Information
11.5.2 Shaanxi Pioneer Biotech Description, Business Overview and Total Revenue
11.5.3 Shaanxi Pioneer Biotech Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Shaanxi Pioneer Biotech Astragaloside IV Products Offered
11.5.5 Shaanxi Pioneer Biotech Recent Development
11.6 Xi'an Lyphar Biotech
11.6.1 Xi'an Lyphar Biotech Corporation Information
11.6.2 Xi'an Lyphar Biotech Description, Business Overview and Total Revenue
11.6.3 Xi'an Lyphar Biotech Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Xi'an Lyphar Biotech Astragaloside IV Products Offered
11.6.5 Xi'an Lyphar Biotech Recent Development
11.7 Xian Pincredit Bio-Tech
11.7.1 Xian Pincredit Bio-Tech Corporation Information
11.7.2 Xian Pincredit Bio-Tech Description, Business Overview and Total Revenue
11.7.3 Xian Pincredit Bio-Tech Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Xian Pincredit Bio-Tech Astragaloside IV Products Offered
11.7.5 Xian Pincredit Bio-Tech Recent Development
11.8 Shaanxi Fuheng (FH) Biotechnology
11.8.1 Shaanxi Fuheng (FH) Biotechnology Corporation Information
11.8.2 Shaanxi Fuheng (FH) Biotechnology Description, Business Overview and Total Revenue
11.8.3 Shaanxi Fuheng (FH) Biotechnology Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Shaanxi Fuheng (FH) Biotechnology Astragaloside IV Products Offered
11.8.5 Shaanxi Fuheng (FH) Biotechnology Recent Development
11.1 NandR Bio Industries
11.1.1 NandR Bio Industries Corporation Information
11.1.2 NandR Bio Industries Description, Business Overview and Total Revenue
11.1.3 NandR Bio Industries Sales, Revenue and Gross Margin (2015-2020)
11.1.4 NandR Bio Industries Astragaloside IV Products Offered
11.1.5 NandR Bio Industries Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Astragaloside IV Market Estimates and Projections by Region
12.1.1 Global Astragaloside IV Sales Forecast by Regions 2021-2026
12.1.2 Global Astragaloside IV Revenue Forecast by Regions 2021-2026
12.2 North America Astragaloside IV Market Size Forecast (2021-2026)
12.2.1 North America: Astragaloside IV Sales Forecast (2021-2026)
12.2.2 North America: Astragaloside IV Revenue Forecast (2021-2026)
12.2.3 North America: Astragaloside IV Market Size Forecast by Country (2021-2026)
12.3 Europe Astragaloside IV Market Size Forecast (2021-2026)
12.3.1 Europe: Astragaloside IV Sales Forecast (2021-2026)
12.3.2 Europe: Astragaloside IV Revenue Forecast (2021-2026)
12.3.3 Europe: Astragaloside IV Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Astragaloside IV Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Astragaloside IV Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Astragaloside IV Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Astragaloside IV Market Size Forecast by Region (2021-2026)
12.5 Latin America Astragaloside IV Market Size Forecast (2021-2026)
12.5.1 Latin America: Astragaloside IV Sales Forecast (2021-2026)
12.5.2 Latin America: Astragaloside IV Revenue Forecast (2021-2026)
12.5.3 Latin America: Astragaloside IV Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Astragaloside IV Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Astragaloside IV Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Astragaloside IV Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Astragaloside IV Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Astragaloside IV Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Astragaloside IV Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Astragaloside IV Product Introduction
1.2 Market Segments
1.3 Key Astragaloside IV Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Astragaloside IV Market Size Growth Rate by Type
1.4.2 0.1
1.4.3 0.98
1.4.4 Others
1.5 Market by Application
1.5.1 Global Astragaloside IV Market Size Growth Rate by Application
1.5.2 Food Industry
1.5.3 Pharmaceuticals Industry
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Astragaloside IV Industry Impact
1.6.1 How the Covid-19 is Affecting the Astragaloside IV Industry
1.6.1.1 Astragaloside IV Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Astragaloside IV Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Astragaloside IV Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Astragaloside IV Market Size Estimates and Forecasts
2.1.1 Global Astragaloside IV Revenue 2015-2026
2.1.2 Global Astragaloside IV Sales 2015-2026
2.2 Astragaloside IV Market Size by Region: 2020 Versus 2026
2.2.1 Global Astragaloside IV Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Astragaloside IV Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL ASTRAGALOSIDE IV COMPETITOR LANDSCAPE BY PLAYERS
3.1 Astragaloside IV Sales by Manufacturers
3.1.1 Astragaloside IV Sales by Manufacturers (2015-2020)
3.1.2 Astragaloside IV Sales Market Share by Manufacturers (2015-2020)
3.2 Astragaloside IV Revenue by Manufacturers
3.2.1 Astragaloside IV Revenue by Manufacturers (2015-2020)
3.2.2 Astragaloside IV Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Astragaloside IV Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Astragaloside IV Revenue in 2019
3.2.5 Global Astragaloside IV Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Astragaloside IV Price by Manufacturers
3.4 Astragaloside IV Manufacturing Base Distribution, Product Types
3.4.1 Astragaloside IV Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Astragaloside IV Product Type
3.4.3 Date of International Manufacturers Enter into Astragaloside IV Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Astragaloside IV Market Size by Type (2015-2020)
4.1.1 Global Astragaloside IV Sales by Type (2015-2020)
4.1.2 Global Astragaloside IV Revenue by Type (2015-2020)
4.1.3 Astragaloside IV Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Astragaloside IV Market Size Forecast by Type (2021-2026)
4.2.1 Global Astragaloside IV Sales Forecast by Type (2021-2026)
4.2.2 Global Astragaloside IV Revenue Forecast by Type (2021-2026)
4.2.3 Astragaloside IV Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Astragaloside IV Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Astragaloside IV Market Size by Application (2015-2020)
5.1.1 Global Astragaloside IV Sales by Application (2015-2020)
5.1.2 Global Astragaloside IV Revenue by Application (2015-2020)
5.1.3 Astragaloside IV Price by Application (2015-2020)
5.2 Astragaloside IV Market Size Forecast by Application (2021-2026)
5.2.1 Global Astragaloside IV Sales Forecast by Application (2021-2026)
5.2.2 Global Astragaloside IV Revenue Forecast by Application (2021-2026)
5.2.3 Global Astragaloside IV Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Astragaloside IV by Country
6.1.1 North America Astragaloside IV Sales by Country
6.1.2 North America Astragaloside IV Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Astragaloside IV Market Facts & Figures by Type
6.3 North America Astragaloside IV Market Facts & Figures by Application
7 EUROPE
7.1 Europe Astragaloside IV by Country
7.1.1 Europe Astragaloside IV Sales by Country
7.1.2 Europe Astragaloside IV Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Astragaloside IV Market Facts & Figures by Type
7.3 Europe Astragaloside IV Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Astragaloside IV by Region
8.1.1 Asia Pacific Astragaloside IV Sales by Region
8.1.2 Asia Pacific Astragaloside IV Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Astragaloside IV Market Facts & Figures by Type
8.3 Asia Pacific Astragaloside IV Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Astragaloside IV by Country
9.1.1 Latin America Astragaloside IV Sales by Country
9.1.2 Latin America Astragaloside IV Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Astragaloside IV Market Facts & Figures by Type
9.3 Central & South America Astragaloside IV Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Astragaloside IV by Country
10.1.1 Middle East and Africa Astragaloside IV Sales by Country
10.1.2 Middle East and Africa Astragaloside IV Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Astragaloside IV Market Facts & Figures by Type
10.3 Middle East and Africa Astragaloside IV Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 NandR Bio Industries
11.1.1 NandR Bio Industries Corporation Information
11.1.2 NandR Bio Industries Description, Business Overview and Total Revenue
11.1.3 NandR Bio Industries Sales, Revenue and Gross Margin (2015-2020)
11.1.4 NandR Bio Industries Astragaloside IV Products Offered
11.1.5 NandR Bio Industries Recent Development
11.2 Zenergy Korea Corporation
11.2.1 Zenergy Korea Corporation Corporation Information
11.2.2 Zenergy Korea Corporation Description, Business Overview and Total Revenue
11.2.3 Zenergy Korea Corporation Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Zenergy Korea Corporation Astragaloside IV Products Offered
11.2.5 Zenergy Korea Corporation Recent Development
11.3 Bio-norm
11.3.1 Bio-norm Corporation Information
11.3.2 Bio-norm Description, Business Overview and Total Revenue
11.3.3 Bio-norm Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Bio-norm Astragaloside IV Products Offered
11.3.5 Bio-norm Recent Development
11.4 Wuhan Vanz Pharm
11.4.1 Wuhan Vanz Pharm Corporation Information
11.4.2 Wuhan Vanz Pharm Description, Business Overview and Total Revenue
11.4.3 Wuhan Vanz Pharm Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Wuhan Vanz Pharm Astragaloside IV Products Offered
11.4.5 Wuhan Vanz Pharm Recent Development
11.5 Shaanxi Pioneer Biotech
11.5.1 Shaanxi Pioneer Biotech Corporation Information
11.5.2 Shaanxi Pioneer Biotech Description, Business Overview and Total Revenue
11.5.3 Shaanxi Pioneer Biotech Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Shaanxi Pioneer Biotech Astragaloside IV Products Offered
11.5.5 Shaanxi Pioneer Biotech Recent Development
11.6 Xi'an Lyphar Biotech
11.6.1 Xi'an Lyphar Biotech Corporation Information
11.6.2 Xi'an Lyphar Biotech Description, Business Overview and Total Revenue
11.6.3 Xi'an Lyphar Biotech Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Xi'an Lyphar Biotech Astragaloside IV Products Offered
11.6.5 Xi'an Lyphar Biotech Recent Development
11.7 Xian Pincredit Bio-Tech
11.7.1 Xian Pincredit Bio-Tech Corporation Information
11.7.2 Xian Pincredit Bio-Tech Description, Business Overview and Total Revenue
11.7.3 Xian Pincredit Bio-Tech Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Xian Pincredit Bio-Tech Astragaloside IV Products Offered
11.7.5 Xian Pincredit Bio-Tech Recent Development
11.8 Shaanxi Fuheng (FH) Biotechnology
11.8.1 Shaanxi Fuheng (FH) Biotechnology Corporation Information
11.8.2 Shaanxi Fuheng (FH) Biotechnology Description, Business Overview and Total Revenue
11.8.3 Shaanxi Fuheng (FH) Biotechnology Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Shaanxi Fuheng (FH) Biotechnology Astragaloside IV Products Offered
11.8.5 Shaanxi Fuheng (FH) Biotechnology Recent Development
11.1 NandR Bio Industries
11.1.1 NandR Bio Industries Corporation Information
11.1.2 NandR Bio Industries Description, Business Overview and Total Revenue
11.1.3 NandR Bio Industries Sales, Revenue and Gross Margin (2015-2020)
11.1.4 NandR Bio Industries Astragaloside IV Products Offered
11.1.5 NandR Bio Industries Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Astragaloside IV Market Estimates and Projections by Region
12.1.1 Global Astragaloside IV Sales Forecast by Regions 2021-2026
12.1.2 Global Astragaloside IV Revenue Forecast by Regions 2021-2026
12.2 North America Astragaloside IV Market Size Forecast (2021-2026)
12.2.1 North America: Astragaloside IV Sales Forecast (2021-2026)
12.2.2 North America: Astragaloside IV Revenue Forecast (2021-2026)
12.2.3 North America: Astragaloside IV Market Size Forecast by Country (2021-2026)
12.3 Europe Astragaloside IV Market Size Forecast (2021-2026)
12.3.1 Europe: Astragaloside IV Sales Forecast (2021-2026)
12.3.2 Europe: Astragaloside IV Revenue Forecast (2021-2026)
12.3.3 Europe: Astragaloside IV Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Astragaloside IV Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Astragaloside IV Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Astragaloside IV Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Astragaloside IV Market Size Forecast by Region (2021-2026)
12.5 Latin America Astragaloside IV Market Size Forecast (2021-2026)
12.5.1 Latin America: Astragaloside IV Sales Forecast (2021-2026)
12.5.2 Latin America: Astragaloside IV Revenue Forecast (2021-2026)
12.5.3 Latin America: Astragaloside IV Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Astragaloside IV Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Astragaloside IV Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Astragaloside IV Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Astragaloside IV Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Astragaloside IV Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Astragaloside IV Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Astragaloside IV Market Segments
Table 2. Ranking of Global Top Astragaloside IV Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Astragaloside IV Market Size Growth Rate by Type 2020-2026 (MT) & (US$ Million)
Table 4. Major Manufacturers of 0.1
Table 5. Major Manufacturers of 0.98
Table 6. Major Manufacturers of Others
Table 7. COVID-19 Impact Global Market: (Four Astragaloside IV Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Astragaloside IV Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Astragaloside IV Players to Combat Covid-19 Impact
Table 12. Global Astragaloside IV Market Size Growth Rate by Application 2020-2026 (MT)
Table 13. Global Astragaloside IV Market Size by Region (MT) & (US$ Million): 2020 VS 2026
Table 14. Global Astragaloside IV Sales by Regions 2015-2020 (MT)
Table 15. Global Astragaloside IV Sales Market Share by Regions (2015-2020)
Table 16. Global Astragaloside IV Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Astragaloside IV Sales by Manufacturers (2015-2020) (MT)
Table 18. Global Astragaloside IV Sales Share by Manufacturers (2015-2020)
Table 19. Global Astragaloside IV Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Astragaloside IV by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Astragaloside IV as of 2019)
Table 21. Astragaloside IV Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Astragaloside IV Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Astragaloside IV Price (2015-2020) (USD/Kg)
Table 24. Astragaloside IV Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Astragaloside IV Product Type
Table 26. Date of International Manufacturers Enter into Astragaloside IV Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Astragaloside IV Sales by Type (2015-2020) (MT)
Table 29. Global Astragaloside IV Sales Share by Type (2015-2020)
Table 30. Global Astragaloside IV Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Astragaloside IV Revenue Share by Type (2015-2020)
Table 32. Astragaloside IV Average Selling Price (ASP) by Type 2015-2020 (USD/Kg)
Table 33. Global Astragaloside IV Sales by Application (2015-2020) (MT)
Table 34. Global Astragaloside IV Sales Share by Application (2015-2020)
Table 35. North America Astragaloside IV Sales by Country (2015-2020) (MT)
Table 36. North America Astragaloside IV Sales Market Share by Country (2015-2020)
Table 37. North America Astragaloside IV Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Astragaloside IV Revenue Market Share by Country (2015-2020)
Table 39. North America Astragaloside IV Sales by Type (2015-2020) (MT)
Table 40. North America Astragaloside IV Sales Market Share by Type (2015-2020)
Table 41. North America Astragaloside IV Sales by Application (2015-2020) (MT)
Table 42. North America Astragaloside IV Sales Market Share by Application (2015-2020)
Table 43. Europe Astragaloside IV Sales by Country (2015-2020) (MT)
Table 44. Europe Astragaloside IV Sales Market Share by Country (2015-2020)
Table 45. Europe Astragaloside IV Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Astragaloside IV Revenue Market Share by Country (2015-2020)
Table 47. Europe Astragaloside IV Sales by Type (2015-2020) (MT)
Table 48. Europe Astragaloside IV Sales Market Share by Type (2015-2020)
Table 49. Europe Astragaloside IV Sales by Application (2015-2020) (MT)
Table 50. Europe Astragaloside IV Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Astragaloside IV Sales by Region (2015-2020) (MT)
Table 52. Asia Pacific Astragaloside IV Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Astragaloside IV Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Astragaloside IV Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Astragaloside IV Sales by Type (2015-2020) (MT)
Table 56. Asia Pacific Astragaloside IV Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Astragaloside IV Sales by Application (2015-2020) (MT)
Table 58. Asia Pacific Astragaloside IV Sales Market Share by Application (2015-2020)
Table 59. Latin America Astragaloside IV Sales by Country (2015-2020) (MT)
Table 60. Latin America Astragaloside IV Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Astragaloside IV Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Astragaloside IV Revenue Market Share by Country (2015-2020)
Table 63. Latin America Astragaloside IV Sales by Type (2015-2020) (MT)
Table 64. Latin America Astragaloside IV Sales Market Share by Type (2015-2020)
Table 65. Latin America Astragaloside IV Sales by Application (2015-2020) (MT)
Table 66. Latin America Astragaloside IV Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Astragaloside IV Sales by Country (2015-2020) (MT)
Table 68. Middle East and Africa Astragaloside IV Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Astragaloside IV Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Astragaloside IV Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Astragaloside IV Sales by Type (2015-2020) (MT)
Table 72. Middle East and Africa Astragaloside IV Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Astragaloside IV Sales by Application (2015-2020) (MT)
Table 74. Middle East and Africa Astragaloside IV Sales Market Share by Application (2015-2020)
Table 75. NandR Bio Industries Corporation Information
Table 76. NandR Bio Industries Description and Major Businesses
Table 77. NandR Bio Industries Astragaloside IV Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 78. NandR Bio Industries Product
Table 79. NandR Bio Industries Recent Development
Table 80. Zenergy Korea Corporation Corporation Information
Table 81. Zenergy Korea Corporation Description and Major Businesses
Table 82. Zenergy Korea Corporation Astragaloside IV Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 83. Zenergy Korea Corporation Product
Table 84. Zenergy Korea Corporation Recent Development
Table 85. Bio-norm Corporation Information
Table 86. Bio-norm Description and Major Businesses
Table 87. Bio-norm Astragaloside IV Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 88. Bio-norm Product
Table 89. Bio-norm Recent Development
Table 90. Wuhan Vanz Pharm Corporation Information
Table 91. Wuhan Vanz Pharm Description and Major Businesses
Table 92. Wuhan Vanz Pharm Astragaloside IV Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 93. Wuhan Vanz Pharm Product
Table 94. Wuhan Vanz Pharm Recent Development
Table 95. Shaanxi Pioneer Biotech Corporation Information
Table 96. Shaanxi Pioneer Biotech Description and Major Businesses
Table 97. Shaanxi Pioneer Biotech Astragaloside IV Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 98. Shaanxi Pioneer Biotech Product
Table 99. Shaanxi Pioneer Biotech Recent Development
Table 100. Xi'an Lyphar Biotech Corporation Information
Table 101. Xi'an Lyphar Biotech Description and Major Businesses
Table 102. Xi'an Lyphar Biotech Astragaloside IV Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 103. Xi'an Lyphar Biotech Product
Table 104. Xi'an Lyphar Biotech Recent Development
Table 105. Xian Pincredit Bio-Tech Corporation Information
Table 106. Xian Pincredit Bio-Tech Description and Major Businesses
Table 107. Xian Pincredit Bio-Tech Astragaloside IV Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 108. Xian Pincredit Bio-Tech Product
Table 109. Xian Pincredit Bio-Tech Recent Development
Table 110. Shaanxi Fuheng (FH) Biotechnology Corporation Information
Table 111. Shaanxi Fuheng (FH) Biotechnology Description and Major Businesses
Table 112. Shaanxi Fuheng (FH) Biotechnology Astragaloside IV Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 113. Shaanxi Fuheng (FH) Biotechnology Product
Table 114. Shaanxi Fuheng (FH) Biotechnology Recent Development
Table 115. Global Astragaloside IV Sales Forecast by Regions (2021-2026) (MT)
Table 116. Global Astragaloside IV Sales Market Share Forecast by Regions (2021-2026)
Table 117. Global Astragaloside IV Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 118. Global Astragaloside IV Revenue Market Share Forecast by Regions (2021-2026)
Table 119. North America: Astragaloside IV Sales Forecast by Country (2021-2026) (MT)
Table 120. North America: Astragaloside IV Revenue Forecast by Country (2021-2026) (US$ Million)
Table 121. Europe: Astragaloside IV Sales Forecast by Country (2021-2026) (MT)
Table 122. Europe: Astragaloside IV Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Asia Pacific: Astragaloside IV Sales Forecast by Region (2021-2026) (MT)
Table 124. Asia Pacific: Astragaloside IV Revenue Forecast by Region (2021-2026) (US$ Million)
Table 125. Latin America: Astragaloside IV Sales Forecast by Country (2021-2026) (MT)
Table 126. Latin America: Astragaloside IV Revenue Forecast by Country (2021-2026) (US$ Million)
Table 127. Middle East and Africa: Astragaloside IV Sales Forecast by Country (2021-2026) (MT)
Table 128. Middle East and Africa: Astragaloside IV Revenue Forecast by Country (2021-2026) (US$ Million)
Table 129. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 130. Key Challenges
Table 131. Market Risks
Table 132. Main Points Interviewed from Key Astragaloside IV Players
Table 133. Astragaloside IV Customers List
Table 134. Astragaloside IV Distributors List
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
Table 1. Astragaloside IV Market Segments
Table 2. Ranking of Global Top Astragaloside IV Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Astragaloside IV Market Size Growth Rate by Type 2020-2026 (MT) & (US$ Million)
Table 4. Major Manufacturers of 0.1
Table 5. Major Manufacturers of 0.98
Table 6. Major Manufacturers of Others
Table 7. COVID-19 Impact Global Market: (Four Astragaloside IV Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Astragaloside IV Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Astragaloside IV Players to Combat Covid-19 Impact
Table 12. Global Astragaloside IV Market Size Growth Rate by Application 2020-2026 (MT)
Table 13. Global Astragaloside IV Market Size by Region (MT) & (US$ Million): 2020 VS 2026
Table 14. Global Astragaloside IV Sales by Regions 2015-2020 (MT)
Table 15. Global Astragaloside IV Sales Market Share by Regions (2015-2020)
Table 16. Global Astragaloside IV Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Astragaloside IV Sales by Manufacturers (2015-2020) (MT)
Table 18. Global Astragaloside IV Sales Share by Manufacturers (2015-2020)
Table 19. Global Astragaloside IV Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Astragaloside IV by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Astragaloside IV as of 2019)
Table 21. Astragaloside IV Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Astragaloside IV Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Astragaloside IV Price (2015-2020) (USD/Kg)
Table 24. Astragaloside IV Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Astragaloside IV Product Type
Table 26. Date of International Manufacturers Enter into Astragaloside IV Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Astragaloside IV Sales by Type (2015-2020) (MT)
Table 29. Global Astragaloside IV Sales Share by Type (2015-2020)
Table 30. Global Astragaloside IV Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Astragaloside IV Revenue Share by Type (2015-2020)
Table 32. Astragaloside IV Average Selling Price (ASP) by Type 2015-2020 (USD/Kg)
Table 33. Global Astragaloside IV Sales by Application (2015-2020) (MT)
Table 34. Global Astragaloside IV Sales Share by Application (2015-2020)
Table 35. North America Astragaloside IV Sales by Country (2015-2020) (MT)
Table 36. North America Astragaloside IV Sales Market Share by Country (2015-2020)
Table 37. North America Astragaloside IV Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Astragaloside IV Revenue Market Share by Country (2015-2020)
Table 39. North America Astragaloside IV Sales by Type (2015-2020) (MT)
Table 40. North America Astragaloside IV Sales Market Share by Type (2015-2020)
Table 41. North America Astragaloside IV Sales by Application (2015-2020) (MT)
Table 42. North America Astragaloside IV Sales Market Share by Application (2015-2020)
Table 43. Europe Astragaloside IV Sales by Country (2015-2020) (MT)
Table 44. Europe Astragaloside IV Sales Market Share by Country (2015-2020)
Table 45. Europe Astragaloside IV Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Astragaloside IV Revenue Market Share by Country (2015-2020)
Table 47. Europe Astragaloside IV Sales by Type (2015-2020) (MT)
Table 48. Europe Astragaloside IV Sales Market Share by Type (2015-2020)
Table 49. Europe Astragaloside IV Sales by Application (2015-2020) (MT)
Table 50. Europe Astragaloside IV Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Astragaloside IV Sales by Region (2015-2020) (MT)
Table 52. Asia Pacific Astragaloside IV Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Astragaloside IV Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Astragaloside IV Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Astragaloside IV Sales by Type (2015-2020) (MT)
Table 56. Asia Pacific Astragaloside IV Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Astragaloside IV Sales by Application (2015-2020) (MT)
Table 58. Asia Pacific Astragaloside IV Sales Market Share by Application (2015-2020)
Table 59. Latin America Astragaloside IV Sales by Country (2015-2020) (MT)
Table 60. Latin America Astragaloside IV Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Astragaloside IV Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Astragaloside IV Revenue Market Share by Country (2015-2020)
Table 63. Latin America Astragaloside IV Sales by Type (2015-2020) (MT)
Table 64. Latin America Astragaloside IV Sales Market Share by Type (2015-2020)
Table 65. Latin America Astragaloside IV Sales by Application (2015-2020) (MT)
Table 66. Latin America Astragaloside IV Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Astragaloside IV Sales by Country (2015-2020) (MT)
Table 68. Middle East and Africa Astragaloside IV Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Astragaloside IV Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Astragaloside IV Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Astragaloside IV Sales by Type (2015-2020) (MT)
Table 72. Middle East and Africa Astragaloside IV Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Astragaloside IV Sales by Application (2015-2020) (MT)
Table 74. Middle East and Africa Astragaloside IV Sales Market Share by Application (2015-2020)
Table 75. NandR Bio Industries Corporation Information
Table 76. NandR Bio Industries Description and Major Businesses
Table 77. NandR Bio Industries Astragaloside IV Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 78. NandR Bio Industries Product
Table 79. NandR Bio Industries Recent Development
Table 80. Zenergy Korea Corporation Corporation Information
Table 81. Zenergy Korea Corporation Description and Major Businesses
Table 82. Zenergy Korea Corporation Astragaloside IV Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 83. Zenergy Korea Corporation Product
Table 84. Zenergy Korea Corporation Recent Development
Table 85. Bio-norm Corporation Information
Table 86. Bio-norm Description and Major Businesses
Table 87. Bio-norm Astragaloside IV Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 88. Bio-norm Product
Table 89. Bio-norm Recent Development
Table 90. Wuhan Vanz Pharm Corporation Information
Table 91. Wuhan Vanz Pharm Description and Major Businesses
Table 92. Wuhan Vanz Pharm Astragaloside IV Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 93. Wuhan Vanz Pharm Product
Table 94. Wuhan Vanz Pharm Recent Development
Table 95. Shaanxi Pioneer Biotech Corporation Information
Table 96. Shaanxi Pioneer Biotech Description and Major Businesses
Table 97. Shaanxi Pioneer Biotech Astragaloside IV Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 98. Shaanxi Pioneer Biotech Product
Table 99. Shaanxi Pioneer Biotech Recent Development
Table 100. Xi'an Lyphar Biotech Corporation Information
Table 101. Xi'an Lyphar Biotech Description and Major Businesses
Table 102. Xi'an Lyphar Biotech Astragaloside IV Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 103. Xi'an Lyphar Biotech Product
Table 104. Xi'an Lyphar Biotech Recent Development
Table 105. Xian Pincredit Bio-Tech Corporation Information
Table 106. Xian Pincredit Bio-Tech Description and Major Businesses
Table 107. Xian Pincredit Bio-Tech Astragaloside IV Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 108. Xian Pincredit Bio-Tech Product
Table 109. Xian Pincredit Bio-Tech Recent Development
Table 110. Shaanxi Fuheng (FH) Biotechnology Corporation Information
Table 111. Shaanxi Fuheng (FH) Biotechnology Description and Major Businesses
Table 112. Shaanxi Fuheng (FH) Biotechnology Astragaloside IV Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 113. Shaanxi Fuheng (FH) Biotechnology Product
Table 114. Shaanxi Fuheng (FH) Biotechnology Recent Development
Table 115. Global Astragaloside IV Sales Forecast by Regions (2021-2026) (MT)
Table 116. Global Astragaloside IV Sales Market Share Forecast by Regions (2021-2026)
Table 117. Global Astragaloside IV Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 118. Global Astragaloside IV Revenue Market Share Forecast by Regions (2021-2026)
Table 119. North America: Astragaloside IV Sales Forecast by Country (2021-2026) (MT)
Table 120. North America: Astragaloside IV Revenue Forecast by Country (2021-2026) (US$ Million)
Table 121. Europe: Astragaloside IV Sales Forecast by Country (2021-2026) (MT)
Table 122. Europe: Astragaloside IV Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Asia Pacific: Astragaloside IV Sales Forecast by Region (2021-2026) (MT)
Table 124. Asia Pacific: Astragaloside IV Revenue Forecast by Region (2021-2026) (US$ Million)
Table 125. Latin America: Astragaloside IV Sales Forecast by Country (2021-2026) (MT)
Table 126. Latin America: Astragaloside IV Revenue Forecast by Country (2021-2026) (US$ Million)
Table 127. Middle East and Africa: Astragaloside IV Sales Forecast by Country (2021-2026) (MT)
Table 128. Middle East and Africa: Astragaloside IV Revenue Forecast by Country (2021-2026) (US$ Million)
Table 129. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 130. Key Challenges
Table 131. Market Risks
Table 132. Main Points Interviewed from Key Astragaloside IV Players
Table 133. Astragaloside IV Customers List
Table 134. Astragaloside IV Distributors List
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Astragaloside IV Product Picture
Figure 2. Global Astragaloside IV Sales Market Share by Type in 2020 & 2026
Figure 3. 0.1 Product Picture
Figure 4. 0.98 Product Picture
Figure 5. Others Product Picture
Figure 6. Global Astragaloside IV Sales Market Share by Application in 2020 & 2026
Figure 7. Food Industry
Figure 8. Pharmaceuticals Industry
Figure 9. Others
Figure 10. Astragaloside IV Report Years Considered
Figure 11. Global Astragaloside IV Market Size 2015-2026 (US$ Million)
Figure 12. Global Astragaloside IV Sales 2015-2026 (MT)
Figure 13. Global Astragaloside IV Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Astragaloside IV Sales Market Share by Region (2015-2020)
Figure 15. Global Astragaloside IV Sales Market Share by Region in 2019
Figure 16. Global Astragaloside IV Revenue Market Share by Region (2015-2020)
Figure 17. Global Astragaloside IV Revenue Market Share by Region in 2019
Figure 18. Global Astragaloside IV Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Astragaloside IV Revenue in 2019
Figure 20. Astragaloside IV Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Astragaloside IV Sales Market Share by Type (2015-2020)
Figure 22. Global Astragaloside IV Sales Market Share by Type in 2019
Figure 23. Global Astragaloside IV Revenue Market Share by Type (2015-2020)
Figure 24. Global Astragaloside IV Revenue Market Share by Type in 2019
Figure 25. Global Astragaloside IV Market Share by Price Range (2015-2020)
Figure 26. Global Astragaloside IV Sales Market Share by Application (2015-2020)
Figure 27. Global Astragaloside IV Sales Market Share by Application in 2019
Figure 28. Global Astragaloside IV Revenue Market Share by Application (2015-2020)
Figure 29. Global Astragaloside IV Revenue Market Share by Application in 2019
Figure 30. North America Astragaloside IV Sales Growth Rate 2015-2020 (MT)
Figure 31. North America Astragaloside IV Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Astragaloside IV Sales Market Share by Country in 2019
Figure 33. North America Astragaloside IV Revenue Market Share by Country in 2019
Figure 34. U.S. Astragaloside IV Sales Growth Rate (2015-2020) (MT)
Figure 35. U.S. Astragaloside IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Astragaloside IV Sales Growth Rate (2015-2020) (MT)
Figure 37. Canada Astragaloside IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Astragaloside IV Market Share by Type in 2019
Figure 39. North America Astragaloside IV Market Share by Application in 2019
Figure 40. Europe Astragaloside IV Sales Growth Rate 2015-2020 (MT)
Figure 41. Europe Astragaloside IV Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Astragaloside IV Sales Market Share by Country in 2019
Figure 43. Europe Astragaloside IV Revenue Market Share by Country in 2019
Figure 44. Germany Astragaloside IV Sales Growth Rate (2015-2020) (MT)
Figure 45. Germany Astragaloside IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Astragaloside IV Sales Growth Rate (2015-2020) (MT)
Figure 47. France Astragaloside IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Astragaloside IV Sales Growth Rate (2015-2020) (MT)
Figure 49. U.K. Astragaloside IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Astragaloside IV Sales Growth Rate (2015-2020) (MT)
Figure 51. Italy Astragaloside IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Astragaloside IV Sales Growth Rate (2015-2020) (MT)
Figure 53. Russia Astragaloside IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Astragaloside IV Market Share by Type in 2019
Figure 55. Europe Astragaloside IV Market Share by Application in 2019
Figure 56. Asia Pacific Astragaloside IV Sales Growth Rate 2015-2020 (MT)
Figure 57. Asia Pacific Astragaloside IV Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Astragaloside IV Sales Market Share by Region in 2019
Figure 59. Asia Pacific Astragaloside IV Revenue Market Share by Region in 2019
Figure 60. China Astragaloside IV Sales Growth Rate (2015-2020) (MT)
Figure 61. China Astragaloside IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Astragaloside IV Sales Growth Rate (2015-2020) (MT)
Figure 63. Japan Astragaloside IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Astragaloside IV Sales Growth Rate (2015-2020) (MT)
Figure 65. South Korea Astragaloside IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Astragaloside IV Sales Growth Rate (2015-2020) (MT)
Figure 67. India Astragaloside IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Astragaloside IV Sales Growth Rate (2015-2020) (MT)
Figure 69. Australia Astragaloside IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Astragaloside IV Sales Growth Rate (2015-2020) (MT)
Figure 71. Taiwan Astragaloside IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Astragaloside IV Sales Growth Rate (2015-2020) (MT)
Figure 73. Indonesia Astragaloside IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Astragaloside IV Sales Growth Rate (2015-2020) (MT)
Figure 75. Thailand Astragaloside IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Astragaloside IV Sales Growth Rate (2015-2020) (MT)
Figure 77. Malaysia Astragaloside IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Astragaloside IV Sales Growth Rate (2015-2020) (MT)
Figure 79. Philippines Astragaloside IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Astragaloside IV Sales Growth Rate (2015-2020) (MT)
Figure 81. Vietnam Astragaloside IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Astragaloside IV Market Share by Type in 2019
Figure 83. Asia Pacific Astragaloside IV Market Share by Application in 2019
Figure 84. Latin America Astragaloside IV Sales Growth Rate 2015-2020 (MT)
Figure 85. Latin America Astragaloside IV Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Astragaloside IV Sales Market Share by Country in 2019
Figure 87. Latin America Astragaloside IV Revenue Market Share by Country in 2019
Figure 88. Mexico Astragaloside IV Sales Growth Rate (2015-2020) (MT)
Figure 89. Mexico Astragaloside IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Astragaloside IV Sales Growth Rate (2015-2020) (MT)
Figure 91. Brazil Astragaloside IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Astragaloside IV Sales Growth Rate (2015-2020) (MT)
Figure 93. Argentina Astragaloside IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Astragaloside IV Market Share by Type in 2019
Figure 95. Latin America Astragaloside IV Market Share by Application in 2019
Figure 96. Middle East and Africa Astragaloside IV Sales Growth Rate 2015-2020 (MT)
Figure 97. Middle East and Africa Astragaloside IV Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Astragaloside IV Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Astragaloside IV Revenue Market Share by Country in 2019
Figure 100. Turkey Astragaloside IV Sales Growth Rate (2015-2020) (MT)
Figure 101. Turkey Astragaloside IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Astragaloside IV Sales Growth Rate (2015-2020) (MT)
Figure 103. Saudi Arabia Astragaloside IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Astragaloside IV Sales Growth Rate (2015-2020) (MT)
Figure 105. U.A.E Astragaloside IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Astragaloside IV Market Share by Type in 2019
Figure 107. Middle East and Africa Astragaloside IV Market Share by Application in 2019
Figure 108. NandR Bio Industries Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Zenergy Korea Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Bio-norm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Wuhan Vanz Pharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Shaanxi Pioneer Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Xi'an Lyphar Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Xian Pincredit Bio-Tech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Shaanxi Fuheng (FH) Biotechnology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. North America Astragaloside IV Sales Growth Rate Forecast (2021-2026) (MT)
Figure 117. North America Astragaloside IV Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Europe Astragaloside IV Sales Growth Rate Forecast (2021-2026) (MT)
Figure 119. Europe Astragaloside IV Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Asia Pacific Astragaloside IV Sales Growth Rate Forecast (2021-2026) (MT)
Figure 121. Asia Pacific Astragaloside IV Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Latin America Astragaloside IV Sales Growth Rate Forecast (2021-2026) (MT)
Figure 123. Latin America Astragaloside IV Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Middle East and Africa Astragaloside IV Sales Growth Rate Forecast (2021-2026) (MT)
Figure 125. Middle East and Africa Astragaloside IV Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Porter's Five Forces Analysis
Figure 127. Channels of Distribution
Figure 128. Distributors Profiles
Figure 129. Bottom-up and Top-down Approaches for This Report
Figure 130. Data Triangulation
Figure 131. Key Executives Interviewed
Figure 1. Astragaloside IV Product Picture
Figure 2. Global Astragaloside IV Sales Market Share by Type in 2020 & 2026
Figure 3. 0.1 Product Picture
Figure 4. 0.98 Product Picture
Figure 5. Others Product Picture
Figure 6. Global Astragaloside IV Sales Market Share by Application in 2020 & 2026
Figure 7. Food Industry
Figure 8. Pharmaceuticals Industry
Figure 9. Others
Figure 10. Astragaloside IV Report Years Considered
Figure 11. Global Astragaloside IV Market Size 2015-2026 (US$ Million)
Figure 12. Global Astragaloside IV Sales 2015-2026 (MT)
Figure 13. Global Astragaloside IV Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Astragaloside IV Sales Market Share by Region (2015-2020)
Figure 15. Global Astragaloside IV Sales Market Share by Region in 2019
Figure 16. Global Astragaloside IV Revenue Market Share by Region (2015-2020)
Figure 17. Global Astragaloside IV Revenue Market Share by Region in 2019
Figure 18. Global Astragaloside IV Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Astragaloside IV Revenue in 2019
Figure 20. Astragaloside IV Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Astragaloside IV Sales Market Share by Type (2015-2020)
Figure 22. Global Astragaloside IV Sales Market Share by Type in 2019
Figure 23. Global Astragaloside IV Revenue Market Share by Type (2015-2020)
Figure 24. Global Astragaloside IV Revenue Market Share by Type in 2019
Figure 25. Global Astragaloside IV Market Share by Price Range (2015-2020)
Figure 26. Global Astragaloside IV Sales Market Share by Application (2015-2020)
Figure 27. Global Astragaloside IV Sales Market Share by Application in 2019
Figure 28. Global Astragaloside IV Revenue Market Share by Application (2015-2020)
Figure 29. Global Astragaloside IV Revenue Market Share by Application in 2019
Figure 30. North America Astragaloside IV Sales Growth Rate 2015-2020 (MT)
Figure 31. North America Astragaloside IV Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Astragaloside IV Sales Market Share by Country in 2019
Figure 33. North America Astragaloside IV Revenue Market Share by Country in 2019
Figure 34. U.S. Astragaloside IV Sales Growth Rate (2015-2020) (MT)
Figure 35. U.S. Astragaloside IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Astragaloside IV Sales Growth Rate (2015-2020) (MT)
Figure 37. Canada Astragaloside IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Astragaloside IV Market Share by Type in 2019
Figure 39. North America Astragaloside IV Market Share by Application in 2019
Figure 40. Europe Astragaloside IV Sales Growth Rate 2015-2020 (MT)
Figure 41. Europe Astragaloside IV Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Astragaloside IV Sales Market Share by Country in 2019
Figure 43. Europe Astragaloside IV Revenue Market Share by Country in 2019
Figure 44. Germany Astragaloside IV Sales Growth Rate (2015-2020) (MT)
Figure 45. Germany Astragaloside IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Astragaloside IV Sales Growth Rate (2015-2020) (MT)
Figure 47. France Astragaloside IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Astragaloside IV Sales Growth Rate (2015-2020) (MT)
Figure 49. U.K. Astragaloside IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Astragaloside IV Sales Growth Rate (2015-2020) (MT)
Figure 51. Italy Astragaloside IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Astragaloside IV Sales Growth Rate (2015-2020) (MT)
Figure 53. Russia Astragaloside IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Astragaloside IV Market Share by Type in 2019
Figure 55. Europe Astragaloside IV Market Share by Application in 2019
Figure 56. Asia Pacific Astragaloside IV Sales Growth Rate 2015-2020 (MT)
Figure 57. Asia Pacific Astragaloside IV Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Astragaloside IV Sales Market Share by Region in 2019
Figure 59. Asia Pacific Astragaloside IV Revenue Market Share by Region in 2019
Figure 60. China Astragaloside IV Sales Growth Rate (2015-2020) (MT)
Figure 61. China Astragaloside IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Astragaloside IV Sales Growth Rate (2015-2020) (MT)
Figure 63. Japan Astragaloside IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Astragaloside IV Sales Growth Rate (2015-2020) (MT)
Figure 65. South Korea Astragaloside IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Astragaloside IV Sales Growth Rate (2015-2020) (MT)
Figure 67. India Astragaloside IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Astragaloside IV Sales Growth Rate (2015-2020) (MT)
Figure 69. Australia Astragaloside IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Astragaloside IV Sales Growth Rate (2015-2020) (MT)
Figure 71. Taiwan Astragaloside IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Astragaloside IV Sales Growth Rate (2015-2020) (MT)
Figure 73. Indonesia Astragaloside IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Astragaloside IV Sales Growth Rate (2015-2020) (MT)
Figure 75. Thailand Astragaloside IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Astragaloside IV Sales Growth Rate (2015-2020) (MT)
Figure 77. Malaysia Astragaloside IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Astragaloside IV Sales Growth Rate (2015-2020) (MT)
Figure 79. Philippines Astragaloside IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Astragaloside IV Sales Growth Rate (2015-2020) (MT)
Figure 81. Vietnam Astragaloside IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Astragaloside IV Market Share by Type in 2019
Figure 83. Asia Pacific Astragaloside IV Market Share by Application in 2019
Figure 84. Latin America Astragaloside IV Sales Growth Rate 2015-2020 (MT)
Figure 85. Latin America Astragaloside IV Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Astragaloside IV Sales Market Share by Country in 2019
Figure 87. Latin America Astragaloside IV Revenue Market Share by Country in 2019
Figure 88. Mexico Astragaloside IV Sales Growth Rate (2015-2020) (MT)
Figure 89. Mexico Astragaloside IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Astragaloside IV Sales Growth Rate (2015-2020) (MT)
Figure 91. Brazil Astragaloside IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Astragaloside IV Sales Growth Rate (2015-2020) (MT)
Figure 93. Argentina Astragaloside IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Astragaloside IV Market Share by Type in 2019
Figure 95. Latin America Astragaloside IV Market Share by Application in 2019
Figure 96. Middle East and Africa Astragaloside IV Sales Growth Rate 2015-2020 (MT)
Figure 97. Middle East and Africa Astragaloside IV Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Astragaloside IV Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Astragaloside IV Revenue Market Share by Country in 2019
Figure 100. Turkey Astragaloside IV Sales Growth Rate (2015-2020) (MT)
Figure 101. Turkey Astragaloside IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Astragaloside IV Sales Growth Rate (2015-2020) (MT)
Figure 103. Saudi Arabia Astragaloside IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Astragaloside IV Sales Growth Rate (2015-2020) (MT)
Figure 105. U.A.E Astragaloside IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Astragaloside IV Market Share by Type in 2019
Figure 107. Middle East and Africa Astragaloside IV Market Share by Application in 2019
Figure 108. NandR Bio Industries Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Zenergy Korea Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Bio-norm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Wuhan Vanz Pharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Shaanxi Pioneer Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Xi'an Lyphar Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Xian Pincredit Bio-Tech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Shaanxi Fuheng (FH) Biotechnology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. North America Astragaloside IV Sales Growth Rate Forecast (2021-2026) (MT)
Figure 117. North America Astragaloside IV Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Europe Astragaloside IV Sales Growth Rate Forecast (2021-2026) (MT)
Figure 119. Europe Astragaloside IV Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Asia Pacific Astragaloside IV Sales Growth Rate Forecast (2021-2026) (MT)
Figure 121. Asia Pacific Astragaloside IV Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Latin America Astragaloside IV Sales Growth Rate Forecast (2021-2026) (MT)
Figure 123. Latin America Astragaloside IV Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Middle East and Africa Astragaloside IV Sales Growth Rate Forecast (2021-2026) (MT)
Figure 125. Middle East and Africa Astragaloside IV Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Porter's Five Forces Analysis
Figure 127. Channels of Distribution
Figure 128. Distributors Profiles
Figure 129. Bottom-up and Top-down Approaches for This Report
Figure 130. Data Triangulation
Figure 131. Key Executives Interviewed
